American Association for Cancer Research
21598290cd140474-sup-131298_2_supp_2711745_ndt2cq.pdf (791.41 kB)

Supplementary Figure S5 from Mutant KRAS–Induced Expression of ICAM-1 in Pancreatic Acinar Cells Causes Attraction of Macrophages to Expedite the Formation of Precancerous Lesions

Download (791.41 kB)
journal contribution
posted on 2023-04-03, 20:45 authored by Geou-Yarh Liou, Heike Döppler, Brian Necela, Brandy Edenfield, Lizhi Zhang, David W. Dawson, Peter Storz

Supplementary Figure S5 shows the treatment schedule (A), additional controls (B), basic complete blood count tests (C), and analysis for T-cells and neutrophils (D) for Figure 3F.



Desmoplasia and an inflammatory environment are defining features of pancreatic cancer. Unclear is how pancreatic cells that undergo oncogenic transformation can cross-talk with immune cells and how this contributes to the development of pancreatic lesions. Here, we demonstrate that pancreatic acinar cells expressing mutant KRAS can expedite their transformation to a duct-like phenotype by inducing local inflammation. Specifically, we show that KRASG12D induces the expression of intercellular adhesion molecule-1 (ICAM-1), which serves as chemoattractant for macrophages. Infiltrating macrophages amplify the formation of KRASG12D-caused abnormal pancreatic structures by remodeling the extracellular matrix and providing cytokines such as TNF. Depletion of macrophages or treatment with a neutralizing antibody for ICAM-1 in mice expressing oncogenic Kras under an acinar cell–specific promoter resulted in both a decreased formation of abnormal structures and decreased progression of acinar-to-ductal metaplasia to pancreatic intraepithelial neoplastic lesions.Significance: We here show that oncogenic KRAS in pancreatic acinar cells upregulates the expression of ICAM-1 to attract macrophages. Hence, our results reveal a direct cooperative mechanism between oncogenic Kras mutations and the inflammatory environment to drive the initiation of pancreatic cancer. Cancer Discov; 5(1); 52–63. ©2014 AACR.This article is highlighted in the In This Issue feature, p. 1

Usage metrics

    Cancer Discovery



    Ref. manager